Francois Lafleur

Francois Lafleur is an accomplished industry leader with extensive experience in clinical operations and medical affairs. Currently serving as Senior Director of Clinical Operations at Schrödinger and Clinical Operations Consultant at Dracen Pharmaceuticals, Francois has successfully led early-stage clinical development initiatives, including those that earned Fast Track status from the FDA. Previous roles include Vice President of Global Medical Affairs at VBL Therapeutics and Vice President of Clinical Operations at Dracen Pharmaceuticals, focusing on strategic clinical development and team leadership. With a background spanning over three decades in various companies, including Ipsen, Helsinn Therapeutics, Celgene, and Pfizer, Francois has demonstrated expertise in driving medical strategy, leading high-performing teams, and implementing innovative approaches in oncology and neurology. Francois holds a Master of Public Health from Columbia University and a Bachelor of Science in Immunology/Microbiology from McGill University.